Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Thinking about BPC 157? Read this first. 5 things to know before your first reconstitution what it actually does, the standard dose, the rest day mistake most people skip, and the legal status The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications BPC 157 Fierce Longevity Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry FOXO4 DRI Peptide: Support Healthy Cellular Aging